3 курс / Фармакология / Фармакотерапия_неотложных_состояний_Справочник_Чернов
.pdf2. #"
16 Watt AH Stephezs MR Buss D; Rout€e@ge PA: AQio@aroze re@uces p€asQa warfariz c€earazce iz Qaz Br J Clin Pharmacol 0:707-709 1985
16^ Bauer ŠA Stezwa€€ M HoQ JR Davis R OpheiQ • Greeze Š: ;hazges iz aztipyrize az@ iz@ocyazize greez kizetics @urizg zife@ipize verapaQi€ az@ @i€tiazeQ therapy Clin Pharmacol Ther 40: ^9- 4 1986
164 ;arruQ G Egaz JM AˆeQethy DR: Di€tiazeQ treatQezt iQpairs hepatic @rug oxi@a- tioz: stu@ies of aztipyrize Clin Pharmacol Ther 40:140-14^ 1986
165 Bro@ie MJ MacPhee GJA: ;arˆaQazepize zeurotoxicity precipitate@ ˆy @i€tiazeQ Br Med J 9 :1170-1171 1986
166 •irch W •€eizˆ€oeseQ ;H Be€z GG: Drug izteractiozs with ca€ciuQ aztagozists Pharmacol Ther 45:109-1^6 1990
167 Macphee GJA ThoQpsoz GG McIzzes GT Bro@ie MJ: VerapaQi€ poteztiates carˆaQazepize zeurotoxicity: a c€izica€€y iQportazt izhiˆitory izteractioz Lancet 1:70070^ 1986
168 Sch€azz •D Myre SA Bottorff MB: PharQacokizetic izteractiozs with ca€ciuQ chazze€ aztagozists (Part I) Clin Pharmacokinet 1 (5):^44-^56 1991
169 BrockQo€€er J NeuQayer HH Wagzer • Weˆer W HeizeQeyer G •ewitz H Roots I: PharQacokizetic izteractioz ˆetweez cyc€osporiz az@ @i€tiazeQ Eur J Clin Pharmacol ^8: ^7- 4 1990
170 Maggio TG Barte€s DW: Izcrease@ cyc€osporize ˆ€oo@ cozceztratiozs @ue to verapaQi€ a@Qizistratioz Drug Intell Clin Pharmacol :705-707 1988
171 Wroˆ€ewski BA Sizger WD Whyte J: ;arˆaQazepize-erythroQyciz izteractioz JAMA55:1165-1167 1986
17 He@Qaz A Azge€iz B Arvi@ssoz A Beck O Dah€•vist R Ni€ssoz B O€ssoz M Schezch-Gustafssoz •: Digoxiz-verapaQi€ izteractioz: re@uctioz of ˆi€iary ˆut zot reza€ @igoxiz c€earazce iz huQazs Clin Pharmacol Ther 49: 56- 6 1991
17^ Tateishi T NakashiQa H Shitou T •uQagai Y Ohashi • Hoso@a S Eˆihara A: Effect of @i€tiazeQ oz the pharQacokizetics of proprazo€o€ Qetopro€o€ az@ atezo€o€ Eur J Clin Pharmacol ^6:67-70 1989
174 Ho€tzQaz JŠ •vaQ D; Berry DA Mottozez Š Borre€€ G Harrisoz ŠI ;ozar@ GJ: The pharQaco@yzaQic az@ pharQacokizetic izteractioz of f€ecaizi@e acetate with proprazo€o€: effects oz car@iac fuzctioz az@ @rug c€earazce Eur J Clin Pharmacol ^^:97-99 1987
175 E@war@s DJ Šavoie R BeckQaz H B€evizs R Ruˆezfire M: The effect of coa@Qizistratioz of verapaQi€ oz the pharQacokizetics az@ Qetaˆo€isQ of •uizi@ize Clin Pharmacol Ther 41:68-7^ 1987
176 Nafziger AN May JJ Bertizo JS: Izhiˆitioz of theophy€€ize e€iQizatioz ˆy @i€tiazeQ therapy J Clin Pharmacol 7(11):86 -865 1987
177 SirQazs SM Pieper JA Ša€oz@e RŠ SQith DG Se€f TH: Effect of ca€ciuQ chazze€ ˆ€ockers oz theophy€€ize @ispositioz Clin Pharmacol Ther 44: 9-^4 1988
178 Bizt AJ Burtt I: A@verse aztiˆiotic @rug izteractioz Drugs 0:57-68 1980
179 ;hristezsez Š• Skoveste@ Š: Izhiˆitioz of @rug Qetaˆo€isQ ˆy ch€oraQphezico€ Lancet:1^97-1^99 1969
180 •oup JR Gi€ˆa€@i M McNaQara P Hi€€igoss DM ;o€ˆuQ WA Bruck E: Izteractioz of ch€oraQphezico€ with phezytoiz az@ phezoˆarˆita€ Clin Pharmacol Ther 4:571-575 1978
181 Prescott ŠF: PharQacokizetic @rug izteractiozs Lancet :1 ^9-1 4^ 1969
18 Vizcezt FM: Phezothiazize-iz@uce@ phezytoiz iztoxicatioz (€etter) Ann Intern Med 9^:56-57 1980
18^ Vesta€ RE •oQhauser DM Ho€€ihe€@ JW Shaz@ DG: Izhiˆitioz of proprazo€o€ Qetaˆo€isQ ˆy ch€orproQazize Clin Pharmacol Ther 5:19- 4 1979
184 MacŠeo@ SM Se€€ers EM Gi€es HG Bi€€izgs BJ Martiz PR Greezˆ€att DJ MarshQaz JA: Izteractioz of @isu€firaQ with ˆezzo@iazepizes Clin Pharmacol Ther 4:58^-589 1978
185 •iorˆoe E: Phezytoiz iztoxicatioz @urizg treatQezt with Aztaˆuse (@isu€firaQ) Epilepsia 7: 4649 1966
186 O€esez OV: Disu€firaQ (AztaˆuseR) as izhiˆitor of phezytoiz Qetaˆo€isQ Acta Pharmacol Toxicol 4:^17-^ 1966
187 Šoi ;M Day JD Jue SG Bush ED ;oste€€o P Dewey ŠV Vesta€ RE: Dose-@epez@ezt izhiˆitioz of theophy€€ize Qetaˆo€isQ ˆy @isu€firaQ iz recoverizg a€coho€ics Clin Pharmacol Ther 45:476-486 1989
188 O'Rei€€y RA: Izteractioz of so@iuQ warfariz az@ @isu€firaQ (Aztaˆuse ) iz Qaz Ann Intern Med 78:7^-76 197^
189 Bartkowski RR Go€@ˆerg ME ŠariŒazi GE Boerzer T: Izhiˆitioz of a€feztazi€ Qetaˆ- o€isQ ˆy erythroQcyciz Clin Pharmacol Ther 46:99-10 1989
190 Mi€es MV Tezzisoz MB: ErythroQyciz effects oz Qu€tip€e-@ose carˆaQazepize kizetics Ther Drug Monit 11:47-5 1989
191 Wozg YY Šu@@ez TM Be€€ RD: Effect of erythroQyciz oz carˆaQazepize kizetics
Clin Pharmacol Ther ^^:460-464 198^
19 Marte€€ R Heizrichs D Sti€€er ;R Jezzer M •eowz PA Dupre J: The effects of erythroQyciz iz patiezts treate@ with cyc€osporize Ann Intern Med 104:660-661 1986 19^ Šie@ho€Q H Nor@iz G: ErythroQyciz-fe€o@ipize izteractioz Ann Pharmacother
5:1007-1008 1991
194 Brazigaz TA Roˆˆiz RA ;a@y WJ Nicko€s JG Ue@a ;T: The effects of erythroQyciz oz the aˆsorptioz az@ @ispositioz kizetics of theophy€€ize Eur J Clin Pharmacol 1:115- 1 0 1981
195 May D; Jarˆoe ;H E€€ezˆurg DT Roe EJ •ariˆo J: The effects of erythroQyciz oz theophy€€ize e€iQizatioz iz zorQa€ Qa€es J Clin Pharmacol :1 5-1^0 198
196 Pau€sez O Hog€uz@ P Ni€ssoz ŠG Bezgtssoz HI: The izteractioz of erythroQyciz with theophy€€ize Eur J Clin Pharmacol ^ :49^-498 1987
197 Reztoz •W Gray JD Huzg OR: Depressioz of theophy€€ize e€iQizatioz ˆy erythroQyciz Clin Pharmacol Ther ^0:4 -4 6 1981
198 Richer ; Mathieu M Bah H Thui€€ex ; Duroux P Giu@ice€€i J-F: Theophy€€ize kizetics az@ vezti€atory f€ow iz ˆrozchia€ asthQa az@ chrozic airf€ow oˆstructioz: izf€u- ezce of erythroQyciz Clin Pharmacol Ther ^1:579-586 198
199 Mac€eo@ SM Gi€es HG Patza€ek G Thiessez JJ Se€€ers EM: DiazepaQ actiozs az@ p€asQa cozceztratiozs fo€€owizg ethazo€ izgestioz Eur J Clin Pharmacol 11:^46-^49 1977
00 ;aru€€i N Mazezti F Ga€€o M Sa€vio€i GF: A€coho€-@rugs izteractioz iz Qaz: a€coho€ az@ to€ˆutaQi@e Eur J Clin Invest 1:4 1-4 4 1971
01 Haefe€i WE Bargetzi MJ Fo€€ath F Meyer UA: Potezt izhiˆitioz of cytochroQe P450IID6 (Deˆriso•uiz 4-hy@roxy€ase) ˆy f€ecaizi@e iz vitro az@ iz vivo J Cardiovasc Pharmacol 15:776-779 1990
0 Grazt SM ;€isso€@ SP: F€ucozazo€e: a review of its pharQaco@yzaQic az@ pharQacokizetic properties az@ therapeutic poteztia€ iz superficia€ az@ systeQic Qycoses Drugs ^9(6):877-916 1990
0^ B€uQ RA Wi€toz JH Hi€€igoss DM Gar@zer MJ Hezry EB Hazisoz NJ Scheztag JJ: Effect of f€ucozazo€e oz the @ispositioz of phezytoiz Clin Pharmacol Ther 49:4 0- 4 5 1991
04 GriQs€ey SR Jazz MW ;arter JG D'Me€€o AP D'Souza MJ: Izcrease@ carˆaQazepize p€asQa cozceztratiozs after f€uoxetize coa@Qizistratioz Clin Pharmacol Ther 50:10-15 1991
05 ŠeŒozc JŠ GusQizi D 8rochar@ P: Isoziazi@ az@ reactioz to cheese (€etter) Ann Intern Med 91:79^ 1979
06 ;urry SH DeVaze ;Š Wo€fe MM: ;iQeti@ize izteractioz with aQitripty€ize Eur J Clin Pharmacol 9:4 9-4^^ 1985
07 DesQoz@ PV Patwar@haz RV Schezker S Speeg •V: Short terQ ethazo€ a@Qizistratioz iQpairs the e€iQizatioz of ch€or@iazepoxi@e iz Qaz Eur J Clin Pharmacol 18: 75-78 1980
08 Greezˆ€att DJ DuhQe DW A€€ez MD •och-Weser J: ;€izica€ toxicity of furoseQi@e iz hospita€ize@ patiezts Am Heart J 94:6-1^ 1977
09 •€otz U ReiQazz IW: De€aye@ c€earazce of @iazepaQ @ue to @Qeti@ize N Engl J Med ^04:101 -1014 1980
10 Ochs HR Greezˆ€att DJ Frie@Qaz H Bursteiz ES Šocziskar A HarQatz JS Sha@er RI: BroQazepaQ pharQacokizetics: izf€uezce of age gez@er ora€ coztraceptives ciQet- i@ize az@ proprazo€ Clin Pharmacol Ther 41:56 -570 1987
11 Ochs HR Greezˆ€att DJ Gug€er R: ;iQeti@ize iQpairs zitrazepaQ c€earazce Clin Pharmacol Ther ^4: 7- ^0 198^
1 Ruffo€o RŠ ThoQpsoz JF Sega€ JŠ: DiazepaQ-ciQeti@ize @rug izteractioz: a c€izica€€y sigzificazt effect South Med J 74:1075-1078 1981
1^ SoQogyi A Gug€er R: Drug izteractiozs with ciQeti@ize Clin Pharmacokinet 7: ^-41 198
Рекомендовано к покупке и изучению сайтом МедУнивер - https://meduniver.com/
2. #"
14 Macphee GJA ThoQpsoz GG Scoˆie G Agzew E Park B• Murray T Mc;o€€ •EŠ Bro@ie MJ: Effects of ciQeti@ize oz carˆaQazepize autoaz@ hetero-iz@uctioz iz Qaz
Br J Clin Pharmacol 18:411-419 1984
15 Ette EI Browz-Awa€a EA Essiez EE: ;h€oro•uize e€iQizatioz iz huQazs: effect of €ow-@ose ciQeti@ize J Clin Pharmacol 7:81^-416 1987
16 SzyQazski S ŠieˆerQaz JA Picou D Masiar S ;ooper T: A case report of ciQeti@izeiz@uce@ c€ozapize toxicity J Clin Psychiatry 5 : 1- 1991
17 Šaˆs RA: Izteractioz of roxati@ize acetate with aztaci@s foo@ az@ other @rugs Drugs ^5(^):8 -89 1988
18 Steizer E Spiza E: Differezces iz the izhiˆitory effect of ciQeti@ize oz @esipraQize Qetaˆo€isQ ˆetweez rapi@ az@ s€ow @eˆriso•uiz hy@roxy€ators Clin Pharmacol Ther 4 : 78- 8 1987
19 Duzse€Qaz PHJM E@gar B: Fe€o@ipize c€izica€ pharQacokizetics Clin Pharmacokinet1(6):418-4^0 1991
0 E@gar B Šuz@ˆorg P Regar@h ;G: ;€izica€ pharQacokizetics of fe€o@ipize: A suQQary Drwgs ^4(^):16- 7 1987
1 Sa€tie€ E E€€ro@t AG Mozk JP Šazg€ey MS: Fe€o@ipize: a review of its pharQaco@y- zaQic az@ pharQacokizetic properties az@ therapeutic use iz hypertezsioz Drugs ^6:^87-4 8 1988
Harvey VJ S€eviz MŠ Di€€oway MR ;€ark PI Johzstoz A Šazt AF: The izf€uezce of ciQeti@ize oz the pharQacokizetics of 5-f€uorouraci€ Br J Clin Pharmacol 18:4 1-4^0 1984
^ AˆeQethy DR Greezˆ€att DJ Sha@er RI: IQipraQize-ciQeti@ize izteractioz: iQpairQezt of c€earazce az@ ezhazce@ aˆso€ute ˆioavai€aˆi€ity J Pharmacol Exp Ther 9:70 - 705 1984
4 Hezaver SA Ho€€ister ŠE: ;iQeti@ize izteractioz with iQipraQize az@ zortripty€ize
Clin Pharmacol Ther ^5:18^-187 1984
5 Bauer ŠA E@war@s AD Raz@o€ph FP: ;iQeti@ize-iz@uce@ @ecrease iz €i@ocaize Qetaˆo€isQ Am Heart J 108:41^-414 1984
6 Fee€y J Wi€kizsoz GR McA€€ister ;B Woo@ AJJ: Izcrease@ toxicity az@ re@uce@ @earazce of €i@ocaize ˆy ciQeti@ize Ann Intern Med 96:59 -594 198
7 Wizg ŠMH Mizers JO Birkett DJ FoQaz@er T Ši€€ywhite • WazwiQo€ruk S: Ši@o- caize @ispositioz-sex @ifferezces az@ effects of ciQeti@ize Clin Pharmacol Ther ^5:695701 1984
8 Guay DRP Meathera€€ R; ;ha€Qers JŠ GrahaQe GR: ;iQeti@ize a€ters pethi@ize @ispositioz iz Qaz Br J Clin Pharmacol 18:907-914 1984
9 Tooz S Davi@soz EM Garstazg FM Batra H Bowes RJ Row€az@ M: The raceQic Qetopro€o€ Hz-aztagozist izteractioz Clin Pharmacol Ther 4^: 8^- 89 1988
^0 Schwartz JB Uptoz RA Šiz ET Wi€€iaQs RŠ Bezet ŠZ: Effect of ciQeti@ize or raziti@ize a@Qizistratioz oz zife@ipize pharQacokizetics az@ pharQaco@yzaQics Clin Pharmacol Ther 4^:67^-680 1988
^1 Mauro VF Mauro ŠS HageQaz JH: A€teratioz of peztoxify€€ize pharQacokizetics ˆy ciQeti@ize J Clin Pharmacol 8:649-654 1988
^ A€gozzize GJ Stewart RB Sprizger P•: Decrease@ c€earazce of phezytoiz with ciQet- i@ize (€etter) Ann Intern Med 95: 4445 1981
^^ Hetze€ DJ Bochzer F Ha€€pike F ShearQaz DJ; Hazz ;S: ;iQeti@ize izteractioz with phezytoiz Br Med J 8 :151 1981
^4 Neuvozez PJ Toko€a RA •aste M: ;iQeti@ize-phezytoiz izteractiozs: effect oz seruQ phezytoiz cozceztratioz az@ aztipyrize test iz Qaz Eur J Clin Pharmacol 1: 15- 0 1981
^5 Sa€eQ RB Bre€az@ BD Mishra S• Jor@az JE: Effect of ciQeti@ize oz phezytoiz seruQ €eve€s Epilepsia 4: 8488 198^
^6 SaQˆo€ N; Uptoz RA ;hreQos AN Šiz ET Wi€€iaQs RŠ: A coQparisoz of the izf€uezce of faQoti@ize az@ ciQeti@ize oz phezytoiz e€iQizatioz az@ hepatic ˆ€oo@ f€ow
Br J Clin Pharmacol 7:8^-87 1989
^7 Verˆeeck R•: PharQacokizetic @rug izteractiozs with zozsteroi@a€ azti-izf€aQQatory @rugs Clin Pharmacokinet 19(1):44-66 1990
^8 Fee€y J Wi€kizsoz GR Woo@ AJJ: Re@uctioz of €iver ˆ€oo@ f€ow az@ proprazo€o€ Qetaˆo€isQ ˆy ciQeti@ize N Engl J Med ^04:69 -695 1981
^9 Huazg SM Weiztrauˆ HS Marriott T8 Marizaz B Aˆe€s R: Etizti@ize-proprazo€o€ izteractioz stu@y iz huQazs J Pharmacokinet Biopharm 15(6):557-568 1987
40 Boehzizgh W: Effect of ciQeti@ize az@ raziti@ize oz p€asQa theophy€€ize iz patiezts with chrozic oˆstructive airways @isease treate@ with theophy€€ize az@ corticosteroi@s
Eur J Clin Pharmacol ^8:4^-45 1990
41 ;aQpˆe€€ MA P€achetka JR Jacksoz JE Mooz JF Fiz€ey PR: ;iQeti@ize @ecreases theophy€€ize c€earazce Ann Intern Med 95:68-69 1981
4 ;€uxtoz RJ Rivera JO Ritsche€ WA Pesce AJ Hazezsoz IB: ;iQeti@ize-theophy€€ize izteractioz (€etter) Ann Intern Med 96:684 198
4^ Jacksoz JE Powe€€ JR Waz@e€€ M Bezt€ey J Dorr R: ;iQeti@ize @ecreases theophy€- €ize c€earazce Am Rev Respir Dis 1 ^:615-617 1981
44 Powe€€ JR Rogers JF Wargiz WA ;ross RE Eshe€Qaz FN: Izhiˆitioz of theophy€€ize c€earazce ˆy ciQeti@ize ˆut zot raziti@ize Arch Intern Med 144:484-486 1984
45 Reitˆerg DP Berzhar@ H Scheztag JJ: A€teratioz of theophy€€ize c€earazce az@ ha€f- €ife ˆy ciQeh@ize iz zorQa€ vo€uzteers Ann Intern Med 95:58 -586 1981
46 Vesta€ RE ;usack BJ Mercer GD Dawsoz GW Park B•: Agizg az@ @rug izteractiozs I Effect of ciQeti@ize az@ sQokizg oz the oxi@atioz of theophy€€ize az@ cortiso€ iz hea€thy Qez J Pharmacol Exp Ther 41:488-499 1987
47 North DS Matterz AŠ •api€ RP Ša€oz@e RŠ: The effect of histaQizereceptor aztagozists oz tocaizi@e pharQacokizetics J Clin Pharmacol 8:640-64^ 1988
48 ;ate EW Rogers JF Powe€€ JR: Izhiˆitioz of to€ˆutaQi@e e€iQizatioz ˆy ciQeti@ize ˆut zot raziti@ize J Clin Pharmacol 6:^7 -^77 1986
49 Muirhea@ MR SoQogyi AA Ro€az PE Bochzer F: Effect of ciQeti@ize oz reza€ az@ hepatic @rug e€iQizatioz: stu@ies with triaQtereze Clin Pharmacol Ther 40:400-407 1986
49a O'Rei€€y RA: ;oQparative izteractioz of ciQeti@ize az@ raziti@ize with raceQic warfariz iz Qaz Arch Intern Med 144:989-991 1984
50 Tooz S Hopkizs •J Garstazg FM Row€az@ M: ;oQparative effects of raziti@ize az@ ciQeti@ize oz the pharQacokizetics az@ pharQaco@yzaQics of warfariz iz Qaz Eur J Clin Pharmacol ^ :165-17 1987
51 •irstez R Ne€soz • SteiziŒazs VW Zech • Haer€iz R: ;€izica€ pharQacokizetics of urapi@i€ Clin Pharmacokinet 14:1 9-140 1988
5 Murphy R Swartz R Watkizs PB: Severe acetaQizophez toxicity iz a patiezt receivizg isoziazi@ Ann Intern Med 11^(10):799-800 1990
5^ Va€sa€az V; ;ooper GŠ: ;arˆaQazepize iztoxicatioz cause@ ˆy izteractioz with isoziazi@ Br Med J 85: 61- 6 198
54 Wright JM Stokes EF Sweezy VP: Isoziazi@-iz@uce@ carˆaQazepize toxicity az@ vice versa: a @ouˆ€e @rug izteractioz N Engl J Med ^07:1^ 5-1^ 7 198
55 •utt H Vereˆe€y • McDowe€€ F: Izhiˆitioz of @iphezy€hy@aztoiz Qetaˆo€isQ iz rats az@ iz rat €iver QicrosoQes ˆy aztituˆercu€ar @rugs Neurology 18:706-710 1968
56 Murray FJ: Outˆreak of uzexpecte@ reactiozs aQozg epi€eptics takizg isoziazi@ Am Rev Respir Dis 86:7 9-7^ 196
57 •az@rotas RJ S€aughter RŠ Brass ; Jusko WJ: •etocozazo€e effects oz Qethy€pre@- ziso€oze @ispositioz az@ their Œoizt suppressioz of ez@ogezous cortiso€ Clin Pharmacol Ther 4 :465-470 1987
58 Mozahaz BP Fergusoz ;Š •i€€eavy ES Š€oy@ B• Troy J ;azti€eza ŠR: Torsa@es @e poiztes occurrizg iz associatioz with terfeza@ize use JAMA 64( 1): 788790 1990
59 Perucca E: PharQacokizetic izteractiozs with aztiepi€eptic @rugs Clin Pharmacokinet 7:57-84 198
60 Hurwitz A Vacek JŠ Botteroz GW SzteQ MI Hughes EM JayaraŒ A: Mexi€etize effects oz theophy€€ize @ispositioz Clin Pharmacol Ther 50: 99-^07 1991
61 Šoi ;M Wei X Vesta€ RE: Izhiˆitioz of theophy€€ize Qetaˆo€isQ ˆy Qexi€etize iz youzg Qa€e az@ feQa€e zozsQokers Clin Pharmacol Ther 49:571-580 1991
6 Az@erssoz T: OQeprazo€e @rug izteractioz stu@ies Clin Pharmacokinet 1(^):195- 1 1991
6^ Gug€er R Jezsez J;: OQeprazo€e izhiˆits oxi@ative @rug Qetaˆo€isQ: stu@ies with @iazepaQ az@ phezytoiz iz vivo az@ 7-ethoxycouQariz iz vitro Gastroenterology 89:1 ^5- 1 41 1985
64 How@ez ;W: ;€izica€ pharQaco€ogy of oQeprazo€e Clin Pharmacokinet 0(1):^8-49 1991
65 Prichar@ PJ Wa€t RP •itchizgQaz G• SoQervi€€e •W ŠazgQaz MJS Wi€€iaQs J Richezs A: Ora€ phezytoiz pharQacokizetics @urizg oQeprazo€e therapy Br J Clin Pharmacol 4:54^-545 1987
Рекомендовано к покупке и изучению сайтом МедУнивер - https://meduniver.com/
2. #"
66 Sutfiz T Ba€Qer • BostroQ H Erikssoz S Hog€uz@ P Pau€sez O: Stereose€ective izteractioz of oQeprazo€e with warfariz iz hea€thy Qez Ther Drug Monit 11:176-184 1989
67 Aˆerzethy DR Greezˆ€att DJ Divo€€ M Arez@t R Ochs HR Sha@er RI: IQpairQezt of @iazepaQ Qetaˆo€isQ ˆy €ow-@ose estrogez-coztaizizg ora€-coztraceptive steroi@s N Engl J Med ^06:791-79 198
68 AˆeQethy DR Greezˆ€att DJ Sha@er RI: IQipraQize @ispositioz iz users of ora€ coztraceptive steroi@s Clin Pharmacol Ther ^5:79 -797 1984
69 DeTeresa E Vera A Ortigosa J Pu€poz ŠA Arus AP DeArtaza M: Izteractioz ˆetweez azticoagu€azts az@ coztraceptives: az uzsuspecte@ fiz@izg Br Med J :1 60-1 61 197970 Šeg€er UF Bezet ŠZ: Marke@ a€teratiozs iz @ose-@epez@ezt pre@ziso€oze kizetics iz
woQez takizg ora€ coztraceptives Clin Pharmacol Ther ^9:4 5-4 9 1986
71 ToQatore •M •azarkowski R Mc;arthy TŠ Gar@zer MJ Yurchak AM Jusko WJ: Effect of chrozic ora€ coztraceptive steroi@s oz theophy€€ize @ispositioz Eur J Clin Pharmacol ^:1 9-1^4 198
7 @e Miraz@a P Goo@ SS Yarchoaz R ThoQas RV B€uQ MR Myers ;E Bro@er S: A€teratioz of zi@ovu@ize pharQacokizetics ˆy proˆezeci@ iz patiezts with AIDS or AIDS-re€ate@ coQp€ex Clin Pharmacol 46:494-500 1989
7^ Hii JTY Duff HJ Burgess ED: ;€izica€ pharQacokizetics of propafezoze Clin Pharmacokinet 1(1):1-10 1991
74 Wagzer F •a€usche D Trezk D Jahzchez E RoskaQQ H: Drug izteractioz ˆetweez propafezoze az@ Qetopro€o€ Br J Clin Pharmacol 4: 1^- 0 1987
75 •ates RE Yee YG •irstez EB: Izteractioz ˆetweez warfariz az@ propafezoze iz hea€thy vo€uzteer suˆŒects Clin Pharmacol Ther 4 :^05-^11 1987
76 DaQ M •ristezsez B Hazsez BS ;hristiazsez J: Izteractioz ˆetweez carˆaQazepize az@ propoxypheze iz Qaz Acta Neurol Scand 56:60 -607 1977
77 AˆeQethy DR Greezˆ€att DJ Stee€ • Sha@er RI: IQpairQezt of hepatic @rug oxi@atioz ˆy propoxypheze Ann Intern Med 97: ^- 4 198
78 Ochs HR Greezˆ€att DJ Verˆurg-Ochs B: Proprazo€o€ izteractiozs with @iazepaQ €o- razepaQ az@ a€prazo€aQ Clin Pharmacol Ther ^6:451-455 1984
79 Brazch RA Shaz@ DG Wi€kizsoz GR Nies AS: The re@uctioz of €i@ocaize c€earazce ˆy @€-proprazo€o€: Az exaQp€e of heQo@yzaQic @rug izteractioz J Pharmacol Exp Ther 184:515-519 197^
80 Ochs HR ;arstezs G Greezˆ€att DJ: Re@uctioz iz €i@ocaize c€earazce @urizg coztizuous izfusioz az@ ˆy coa@Qizistratioz of proprazo€o€ N Engl J Med ^0^:^7^-^77 198081 •uh€Qazz J DohrQazz M Marciz S: Effects of •uizi@ize oz pharQacokizetics az@ pharQaco@yzaQics of @igitoxiz achievizg stea@y-state coz@itiozs Clin Pharmacol Ther
^9: 8894 1986
8 He@Qaz A Azge€iz B Arvi@ssoz A Dah€•vist R Ni€ssoz B: Izteractiozs iz the reza€ az@ ˆi€iary e€iQizatioz of @igoxiz: stereose€ective @ifferezce ˆetweez •uizize az@ •uizi- @ize Clin Pharmacol Ther 47: 0- 6 1990
8^ Brosez • GraQ ŠF: Quizi@ize izhiˆits the -hy@roxy€atioz of iQipraQize az@ @esipraQize ˆut zot the @eQethy€atioz of iQipraQize Eur J Clin Pharmacol ^7:155-160 198984 Fuzck-Breztazo ; •roeQer H• Pav€ou H Woos€ey RŠ Ro@ez DM: Gezetica€€y- @eterQize@ izteractioz ˆetweez propafezoze az@ €ow @ose •uizi@ize: ro€e of active Qe-
taˆo€ites iz Qo@u€atizg zet @rug effect Br J Clin Pharmacol 7:4^5-444 1989
85 Zhou HH Azthozy ŠB Ro@ez DM Woo@ AJJ: Quizi@ize re@uces c€earazce of (+)- proprazo€o€ Qore thaz (-)-proprazo€o€ through Qarke@ re@uctioz iz 4-hy@roxy€atioz
Clin Pharmacol Ther 47:686-49^ 1990
86 E@war@s DJ Bow€es S• Svezssoz ;• Ryˆak MJ: Izhiˆitioz of @rug Qetaˆo€isQ ˆy •uizo€oze aztiˆiotics Clin Pharmacokinet 15:19404 1988
87 Hezwoo@ JM Mozk JP: Ezoxaciz: a review of its aztiˆacteria€ activity pharQacokizetic properties az@ therapeutic use Drugs ^6:^ -66 1988
88 Vazce-Bryaz • Guay DRP Rotschafer J;: ;€izica€ pharQacokizetics of ciprof€oxaciz Clin Pharmacokinet 19(6):4^4-461 1990
89 BeckQazz J E€saper W Guz@ert-ReQy U HertraQpf R: Ezoxaciz - a potezt izhiˆitor of theophy€€ize Qetaˆo€isQ Eur J Clin Pharmacol ^^: 7- ^0 1987
90 Bow€es S• Popovski Z Ryˆak MJ BeckQaz HB E@war@s DJ: Effect of zorf€oxaciz oz theophy€€ize pharQacokizetics at stea@y state Antimicrob Agents Chemother ^ (4):51051 1988
91 Raoof S Wo€€sch€ager ; •haz FA: ;iprof€oxaciz izcreases seruQ €eve€s of theophy€€ize Am J Med 8 (4A):115-118 1987
9 Rogge M; So€oQoz WR Se@Qaz AJ We€€izg PG •oup JR Wagzer JG: The theo- phy€€ize-ezoxaciz izteractioz: II ;hazges iz the @ispositioz of theophy€€ize az@ its Qetaˆo€ites @urizg izterQittezt a@Qizistratioz of ezoxaciz Clin Pharmacol Ther 46:4 0- 4 8 1989
9^ Rogge M; So€oQoz WR Se@Qaz AJ We€€izg PG Toothaker RD Wagzer JG: The theophy€€ize-ezoxaciz izteractioz I Effect of ezoxaciz @ose size oz theophy€€ize @ispositioz Clin Pharmacol Ther 44:579-587 1988
94 Sazo M •awakatus • Ohkita ; YaQaQoto I TakeyaQa M YaQashiza H Goto M: Effects of ezoxaciz of €oxaciz az@ zorf€oxaciz oz theophy€€ize @ispositioz iz huQazs
Eur J Clin Pharmacol ^5:161-165 1988
95 Schwartz J Jauregui Š Šettieri J BachQazz •: IQpact of ciprof€oxaciz oz theophy€€ize c€earazce az@ stea@y-state cozceztratiozs iz seruQ Antimicrob Agents Chemother ^ (1)75-77 1988
96 Takagi • Hasegawa T YaQaki • Suzuki R Watazaˆe T Satake T: Izteractioz ˆetweez theophy€€ize az@ ezoxaciz Intern J Clin Pharmacol Ther Toxicol 6(6): 88- 9 1988
97 WiŒzaz@s WJA Vree TB Baars AM vaz Herwaar@ez ;ŠA: Stea@y-state kizetics of the •uizo€oze @erivatives ofioxaciz ezoxaciz ciprof€oxaciz az@ pef€oxaciz @urizg Qaiztezazce treatQezt with theophy€€ize Drugs ^4(1):159-169 1987
98 Tooz S Hopkizs •J Garstazg FM Aarozs Š Se@Qaz A Row€az@ M: Ezoxaciz-war- fariz izteractioz: pharQacokizetic az@ stereocheQica€ aspects Clin Pharmacol Ther 4 :^^-41 1987
99 •aˆizs SA: Izteractiozs aQozg aztiˆiotics az@ other @rugs JAMA 19: 06- 1 197 ^00 ŠuQho€tz B Siersˆaek-Nie€sez • Skovste@ Š •aQpQazz J Hezsez JM: Su€faQe-
thizo€e-iz@uce@ izhiˆitioz of @iphezy€hy@aztoiz to€ˆutaQi@e az@ warfariz Qetaˆo€isQ
Clin Pharmacol Ther 17:7^1-7^4 1975
^01 Tooz S Šow Š• Giˆa€@i M Trager WF O'Rei€€y RA Mot€ey ;H Gou€art DA: The warfariz-su€fizpyrazoze izteractioz: stereocheQica€ cozsi@eratiozs Clin Pharmacol Ther ^9:15- 4 1986
^0 Šo@wick R Mc;ozkey B Browz AM: Šife threatezizg izteractioz ˆetweez taQoxifez az@ warfariz Br Med J 95:1141 1987
^0^ ;o€€i A Buccizo G ;occio€o M Parravi@zi R E€€i GM Sca€trizi G: Tic€opi@izetheophy€€ize izteractioz Clin Pharmacol Ther 41:^58-^6 1987
^04 Macphee GJA Mitche€€ JR WiseQaz Š McŠeHaz AR Park B• McIzzes GT Bro@ie MJ: Effect of so@iuQ va€proate oz carˆaQazepize @ispositioz az@ psychoQotor profi€e iz Qaz Br J Clin Pharmacol 5:59-66 1988
^05 AheQe GW Pia€€ E Marks V Mou€@ G White WF: Pro€ozgatioz az@ ezhazceQezt of seruQ Qethotrexate cozceztratiozs ˆy proˆezeci@ Br Med J 1:1097-1099 1978
^06 Baˆer N Ha€€i@ay Š Siˆeoz R Šitt€er T OrQe MŠ'E: The izteractioz ˆetweez iz@o- Qethaciz az@ proˆezeci@ A c€izica€ az@ pharQacokizetic stu@y Clin Pharmacol Ther4: 98-^06 1978
^07 Griffith RS B€ack HR Brier GŠ Wo€zy JD: Effect of proˆezeci@ oz the ˆ€oo@ €eve€s az@ urizary excretioz of cefaQaz@o€e Antimicrob Agents Chemother 11:809-81 1977
^08 •aQpQazz J Hazsez JM Siersˆaek-Nie€sez • Šaursez H: Effect of soQe @rugs oz pezici€€iz ha€f-€ife iz ˆ€oo@ Clin Pharmacol Ther 1^:516-519 197
^09 Šee BŠ Me@iza I Bezowitz NŠ Jacoˆ P Wofsy ;B Mi€€s J: Dapsoze triQethopriQ az@ su€faQethoxazo€e p€asQa €eve€s @urizg treatQezt of pzeuQocystis pzeuQozia iz patiezts with the ac•uire@ iQQuzo@eficiezcy syz@roQe (AIDS): evi@ezce of @rug izteractiozs Ann Intern Med 110:606-611 1989
^10 May ;D Jarˆoe ;H: Izhiˆitioz of c€earazce of @yphy€€ize ˆy proˆezeci@ (€etter) N Engl J Med ^04:791 1981
^11 Ng HW• Ma@ar€aze AW GrahaQ RM Verˆov JŠ: Near fata€ @rug izteractiozs with Qethotrexate givez for psoriasis Br Med J 95:75 1987
^1 Nierezˆerg DW: ;oQpetitive izhiˆitioz of Qethotrexate iz ki@zey s€ices ˆy zozsteroi@a€ azti-izf€aQQatory @rugs J Pharmacol Exp Ther 6:1-6 198^
^1^ Pere€ JM Daytoz PG Sze€€ MM Yu TF GutQaz AB: Stu@ies of izteractiozs aQozg @rugs iz Qaz at the reza€ €eve€: proˆezeci@ az@ su€fizpyrazoze Clin Pharmacol Ther 10:8^4-840 1969
^14 Rose HJ Pruitt AW Daytoz PG McNay JŠ: Re€atiozship of urizary furoseQi@e excretioz rate to zatriuretic effect iz experiQezta€ azoteQia J Pharmacol Exp Ther 199:490497 1976
^15 Rose HJ Pruitt AW McNay J: Effect of experiQezta€ azoteQia oz reza€ c€earazce of furoseQi@e iz the @og J Pharmacol Exp Ther 196: ^8- 47 1976
Рекомендовано к покупке и изучению сайтом МедУнивер - https://meduniver.com/
2. #"
^16 Sazchez G: EzhazceQezt of hepariz effect ˆy proˆezeci@ (€etter) N Engl J Med 9 :48 1975
^17 Sweezey •R ;haproz DJ Braz@t JŠ GoQo€iz IH Feig PU •raQer PA: Toxic izteractioz ˆetweez acetazo€aQi@e az@ sa€icy€ate: case reports az@ a pharQacokizetic exp€a- zatioz Clin Pharmacol Ther 40:518-5 4 1986
^18 Wesse€izg H Mo€s-Thurkow I: Izteractioz of @iphezy€hy@aztoiz (DPH) az@ to€ˆutaQi@e iz Qaz Eur J Clin Pharmacol 8:75-78 1975
^19 ;hristiaz ;D Mere@ith ;G Speeg •V: ;iQeti@ize izhiˆits reza€ procaizaQi@e c€earazce Clin Pharmacol Ther ^6: 1- 7 1984
^ 0 Hughes B Dyer JE Schwartz AB: Izcrease@ procaizaQi@e p€asQa cozceztratiozs cause@ ˆy •uizi@ize: a zew @rug izteractioz Am Heart J 114(4;1):908-909 1987
^ 1 •osog€ou T Rocci MŠ V€asses PH: TriQethopriQ a€ters the @ispositioz of procaizaQi@e az@ N-acety€procaizaQi@e Clin Pharmacol Ther 44:467-477 1988
^ Peters Š: Reza€ tuˆu€ar excretioz of orgazic ˆases PharQaco€ Rev 1 :1-^5 1960
^ ^ Rezzick BR: Reza€ tuˆu€e trazsport of orgazic catiozs Am J Physiol 40:F8^-F89 1981 ^ 4 SoQogyi A Bochzer F: Dose az@ cozceztratioz @epez@ezt effect of raziti@ize oz procaizaQi@e @ispositioz az@ reza€ c€earazce iz Qaz Br J Clin Pharmacol 18:175-181 1984 ^ 5 SoQogyi A McŠeaz A Heizzow B: ;iQeti@ize-procaizaQi@e pharQacokizetic izteractioz iz Qaz: evi@ezce of coQpetitioz for tuˆu€ar secretioz of ˆasic @rugs Eur J Clin
Pharmacol 5:^^9-^45 198^
#
,-.,/043-,@1< @-1 @0P3P20E 2390A4,40P20A41a
o% …= “ … %“2=2% …%“2$“ O“ =“2% “ " …, “ 3“ C= , …2%" “ …=.% ?,.“ “ "“ *!,2, “*,.“ “%“2% …, . “ p=“C!%“2!=… ……%“2$“ 2%L“ “ !$ ƒ…%L“ C!%K /“ %K3“ %" …=“ %K, , “ ƒ=K% "=…,L “ *%2%!/ “% 32“ C!,"% ,2$“ *“ C%!=› …, “ C% * “ h…2 …“,"…= “ 2 !=C, “ … %K.% , =“ C!,“ ,C%"% ,, “ 3 … 2 …,,“ “ ! …%L“ 2 $…%“2, “ …=!3 …, .““%“3 ,“2%L“ 2,% % ,, “C !", …/.“ƒ=K% "=…, .“C% * “ "=“*3 ,2=. “ ,C%2 …ƒ,, “ = ! , “*,.“ ! =* , . “ C%"! › …, .“ *=…= $ " “ %K“2!3* ,,“ % "/"% ?,.“ C32 L “ b“ “ 2,“ “%“2% …, “% 32“C!,"% ,2$“*“!=ƒ",2, “%“2!%L“C% …%L“… %“2=2% …%“2, “
l…% , “ C! C=!=2/“ ,“ ,.“ 2=K% ,2/“ !=ƒ!3 = 2“ “ ,Z, ,“ "/"% 2“ “ C% *= , “ o% 2% 3“ !=““ %2! …, “ !=ƒ , …/.“ =“C *2%"“ -=! =*%2 !=C,,“ *!,2, “*,.“ “%“2% …,L“ 3“ C= , …2%"“ "“ 3“ %", .“ %“2!%L“ , ,“ .!%…, “*%L“ C% …%L“ … %“2=2% …%“2,“ C!,%K! 2= 2“ % !% … L “ ƒ…= …, “ l/“ %› “ % …,2$“ “%“2% …, “ C% …/.“ -3…* ,L“ !=ƒ , …/ ,“ “C%“%K= , “ nC! …, “ ,3! ƒ= “ =ƒ%2=% ",…/ “ *%… …2!= ,,“ , “ 2%“ %“%K ……%“ "=›…% “ * ,! …“=“ *! =2,…,…=“C%ƒ"% 2“* ,…, ,“23““3 ,2$“%“2% “…=“*% $*%“.%!% %“ C% *,“ % 32“ 3 =“2"%"=2$“ "“ %K “C …,,“ = *"=2…%L“ -=! =*%*,… 2,*, “ b“ %C% … …, “*“…=!3 …, “ 2=K% , “*,.“,“*“*! 2%!…/.“ -3…* ,L “ C% …= “ … %“2=2% …%“2$“ C!,"% ,2“ *“ !=ƒ",2, “ *2!% ,2…/. “ *,“ %2…%[? % …/. “ ,!*3 2%!…/. “ 2!%-, “*,.“ ,“ =› “ =2% % , “*,.“ !=““2!%L“2" “ qC ,= ,“2/ “ !=K%2= ?, “ "“ %K =“2,“ ,…2 …“,"…%L“ 2 !=C,, “ … “ "“ “%“2% …,,“ 3 !›,"=2$“ "“ C= 2,“ "“ “ 2= ,“ -=! =*%2 !=C,,“ "“ 3“ %", .“ C% …%L“ ,“-3…* ,,“ C!,“ …= , ,,“ , ,“ %2“32“2",,“ ,= ,ƒ=“ ,“%-, $2!= ,, “ o%“ 2, “ “%%K!=› …, “ "“ %C% … …, “ *“ ! *% … = , “ C%“ ! 3 ,!%"=…, “ %ƒ“ ,“ =“2%2/“ C!, = …=ƒ…= = /.“ ,*= …2%"“ › =2 $…%“ C!%"% ,2$“ %…,2%[ !,!%"=…, “ *%… …2!= ,,“ *=!“2" ……/.“ " ? “2"“ "“ *!%", “ o%“… …, “="2%!%" “,ƒ“"“ .“ ="“ 2%L“*…, ,“, ……%“! *% … = ,,“C%“
a l=2 !,= /“ =……%L“ ="/“C% %2%" …/““ 3 ?, ,“="2%!= ,:“2=K “^ 1[^ ^ “^ 5 “ ^ 6“ ,“ ^ 9“ C% %2%" …/“ Wezdy“ Š “ St “ Peter “ P”arm D “ ,“ ;”ar€es“ E “ Ha€stezs<z “ P”arm D “F ; ; P ;“2=K “^ 4“C% %2%" …=“Berti€“• J “Wagzer “P”arm D “David“M “ Azgaraz“M S “F ; ; P “F A S H P “,“David“W “Fu”s “M S “P”arm D ;“2=K “^ 7“,“^ 8“ K/ ,“C% %2%" …/“R<ˆert“;”asse “M D “
Рекомендовано к покупке и изучению сайтом МедУнивер - https://meduniver.com/
|
|
-=! =*%2 !=C,,“ C!,“ C% …%L“ ,“ C …% …%L“ … %“2=2% …%“2,“ K3 32“ …=,K% “ =“2%“ ,“C% $ƒ%"=2$“ “ ,2=2 , “ ‚=……= “ ="=“ “% !›,2““ 3 ?3 “,…-%! = , :“
1 %! 3 /“ “%C! …, “* ,! …“=“*! =2,…,…=“(2=K “^ 1)b , …, “C% …%L“… %“2=2% …%“2,“…=“%K• “!=“C! …,
!=ƒ , …/.“C! C=!=2%"“(2=K “^ )
^ ,% %“23C…%“2$“ !=ƒ , …/.“ =…2, ,*!%K…/.“ C! C=!=2%" C%“ “ ,…2!=C !,2%… = $…% %“ …=ƒ…= …, “ 3“ C= , …2%"“ C!, …= , ,,“, ,“%2“32“2",,“C !,2%…,2=“(2=K “^ ^)
4 j%!! * , “ %ƒ“ *=!“2" ……/.“ C! C=!=2%"“ C!,“ C% …%L … %“2=2% …%“2,“(2=K “^ 4)
5 x,!%*%“ ,“C% $ƒ3 / “ "“ 3“ %", .“ ,…2 …“,"…%L“ 2 !=C,, C! C=!=2/:“ *%!! * , “ %ƒ“ ““ 3 2% “ “%“2% …, “ -3…* ,, C% *“,“C!, … …, “ ,= ,ƒ=“(2=K “^ 5)
6 o! C=!=2/ “ C!, … / “ C!,“ …,,“ %“2!%L“ C% …%L … %“2=2% …%“2,“(2=K “^ 6)
7 c!3CC/“ ,3! 2,*%"“(2=K “^ 7)
8 Š,=ƒ, %"/ “ ,3! 2,*,“(2=K “^ 8)
o! C=!=2/ “ ,“C% $ƒ3 / “ …, ,C !*= , ,,““ (2=K “^ 9)
|
3. |
|
|
|
5 6 H676 %! 3 /“ “%C! …, “* ,! …“=“*! =2,…,…=a |
|
|
|
yz3z=yG ;?A ;{D a b |
|
|
|
|
x a ne : ", 2.b | |
|
|
? 8 |
d z= |
|
|
x *%L e+lj |
|
|
|
;}4= 4 ;Dh a b |
|
|
|
|
x | ~ o+f : ae+ ef ", 2.b• ~ : ae+ef z=b• |
|
|
? 8 |
d z= |
|
|
x | ~ j+f : ae+ dn ", 2.b• ~ : ae+ef z=b• |
||
|
|
n+n z= |
|
a4%ƒ!=“2“"“ % =.;“Wt“O“ =““=“2 =“"“* ;“S–r“O“*%… …2!= , “*! =2,…,…=“" “/"%!%2* “*!%", “
5 6 H6G6 b , …, “C% …%L“… %“2=2% …%“2,“…=“%K• “!=“C! …, “(Vd) !=ƒ , …/.“C! C=!=2%"a “
' Vd |
' : Vd |
]*!- /!' ], "/! !' J .! !6 V 7 ," !' V 7"'!/!# V 7"-2!.!' V 7% "-2!* 5 "7!< . 5 "-2 /! !'
_!- "-2 /! !'
c !. "*!/!' H% "2 *!#'. *!/!' `,"'! ,!# R"-2 -. * W $ "-2 ' H '!."!'
Z% 07 * ."$! ,!' \ !* ."$ !* K '-"*!/!'
T " *7 '!-" _!8"-2!' c. *<%." R .!/! !'!'#" "
a“` =C2,!%"=…%“,ƒ“Matzke“GR “Frye“RF:“Drug“d<sizg“iz“˜atiezts“wit”“im˜aired“reza€“ fuz–ti<z “Iz“DiPir<“JT “Ta€ˆert“RŠ “Hayes“PE “Yee“G; “Matzke“GR “P<sey“ŠM“(eds):“
Pharmacotherapy: A Pathophysiologic Approach.“A˜˜€et<z“&“Šazge “N<rwa€k “;T “199^ “ ˜˜“750[76^ “
5 6 H6H6 ,% %“23C…%“2$“!=ƒ , …/.“=…2, ,*!%K…/.“C! C=!=2%"“C%“ ,…2!=C !,2%… = $…% %“…=ƒ…= …, “3“C= , …2%"“C!,“…= , ,,“, ,“%2“32“2",,“ C !,2%…,2=a“
& |
! " |
# |
* |
|
|
( ) |
(%) |
! |
|
|
|
]*!- /!' |
d+j *8 -8 |
j |
jf n |
'. *!/!' |
ee *8 |
g |
no j |
|
*8 -8 |
g |
ln |
|
d+j *8 -8 |
g |
go |
|
|
g |
lj€ |
\"< *!/!' |
*8 -8 |
g |
df e |
|
+j *8 -8 |
n |
j |
|
ee *8 |
g |
lj |
Z. $."*!/!' |
ee *8 |
g |
dj€ |
Рекомендовано к покупке и изучению сайтом МедУнивер - https://meduniver.com/